المؤلفون: Charlotte Buch Jensen, Peter Michael Vestlev, Erik Jakobsen, Hella Danø, Sven Tyge Langkjer, T. Dongsgaard, Adam Luczak, J. Neimann, Anne Sofie Brems-Eskildsen, Søren Linnet

المصدر: Brems-Eskildsen, A S, Linnet, S, Danø, H, Luczak, A, Vestlev, P M, Jakobsen, E H, Neimann, J, Jensen, C B, Dongsgaard, T & Langkjer, S T 2021, ' Metronomic treatment of vinorelbine with oral capecitabine is tolerable in the randomized Phase 2 study XeNa including patients with HER2 non-amplified metastatic breast cancer ', Acta Oncologica, vol. 60, no. 2, pp. 157-164 . https://doi.org/10.1080/0284186X.2020.1851045Test

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Receptor, ErbB-2, Phases of clinical research, Breast Neoplasms, Vinorelbine, Vinblastine, 030218 nuclear medicine & medical imaging, Capecitabine, 03 medical and health sciences, 0302 clinical medicine, Breast cancer, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, randomized trial, Humans, Radiology, Nuclear Medicine and imaging, Dosing, Neoplasm Metastasis, metronomic treatment, business.industry, Cancer, Hematology, General Medicine, medicine.disease, Metastatic breast cancer, Treatment Outcome, 030220 oncology & carcinogenesis, Female, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2101a4cbcc0032e69ac0121949ed806fTest
https://vbn.aau.dk/da/publications/76bfbc2e-c9a4-4913-af91-571e16566305Test

المؤلفون: Noemia Afonso, Marina Cazzaniga, Xavier Pivot, Edgar Petru, Sven Tyge Langkjer, Valter Torri, Pedro Sánchez Rovira, Patricia Gomez, Guido Bocci, Piotr J. Wysocki, Elisabetta Munzone

المساهمون: Cazzaniga, M, Munzone, E, Bocci, G, Afonso, N, Gomez, P, Langkjer, S, Petru, E, Pivot, X, Sanchez Rovira, P, Wysocki, P, Torri, V

المصدر: Cazzaniga, M E, Munzone, E, Bocci, G, Afonso, N, Gomez, P, Langkjer, S, Petru, E, Pivot, X, Sánchez Rovira, P, Wysocki, P & Torri, V 2019, ' Pan-European Expert Meeting on the Use of Metronomic Chemotherapy in Advanced Breast Cancer Patients : The PENELOPE Project ', Advances in Therapy, vol. 36, no. 2, pp. 381-406 . https://doi.org/10.1007/s12325-018-0844-4Test

مصطلحات موضوعية: Oncology, 030213 general clinical medicine, medicine.medical_specialty, Consensus, medicine.medical_treatment, Advanced breast, Breast Neoplasms, Disease, Vinorelbine, 03 medical and health sciences, Breast cancer, 0302 clinical medicine, Consensus meeting, Metronomic chemotherapy, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Humans, Medicine, Pharmacology (medical), Aged, Oncologists, Chemotherapy, Antineoplastic Combined Chemotherapy Protocol, Dose-Response Relationship, Drug, business.industry, Cancer, General Medicine, Middle Aged, medicine.disease, Antineoplastic Agents, Phytogenic, Metronomic Chemotherapy, Metastatic breast cancer, 030220 oncology & carcinogenesis, Administration, Metronomic, Oncologist, MED/06 - ONCOLOGIA MEDICA, Female, business, Breast Neoplasm, Human, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7cf02b52919571c0c19aec7ae3255511Test
https://doi.org/10.1007/s12325-018-0844-4Test

المؤلفون: Max Norman Tandrup, Lambert, Sven Tyge, Langkjer, Per Bendix, Jeppesen

المصدر: Ugeskrift for laeger. 182(21)

مصطلحات موضوعية: Bone Diseases, Metabolic, Dietary Supplements, Humans, Estrogens, Female, Isoflavones

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=pmid________::f3eb2856eca7328f88ec67945252f135Test
https://pubmed.ncbi.nlm.nih.gov/32515321Test

المؤلفون: Ida Kappel Buhl, Troels Dreier Christensen, Anna Sofie Kappel Buhl, Ib Jarle Christensen, Eva Balslev, Ann Søegaard Knop, Bent Ejlertsen, Iben Kümler, Hella Danø, Adam Andrzej Luczak, Sven Tyge Langkjer, Søren Linnet, Erik Hugger Jakobsen, Jurij Bogovic, Vesna Glavicic, Ulla Hald Buhl, Steen Knudsen, Peter Buhl Jensen, Dorte Nielsen

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::1f74f0164074f9f5c285dc7b7b2cb16bTest
https://doi.org/10.21203/rs.2.10981/v1Test

المؤلفون: S Filipović, Carlos H. Barrios, B Yao, Anil A. Joy, A. Chan, S Chia, S. Moran, Miguel Martin, Beverly Moy, Bent Ejlertsen, R De Boer, Y. Ye, Noa Ben-Baruch, Michael Gnant, Richard A. Bryce, David Cella, Lesley Fallowfield, Sven Tyge Langkjer, Suzette Delaloge, Noelia Martínez, Francis M. Senecal, Frankie A. Holmes, A. Ciceniene, Hiroji Iwata, Janine Mansi, Snezhana Smichkoska, Marc Buyse, A.H. Auerbach

المصدر: Delaloge, S, Cella, D, Ye, Y, Buyse, M, Chan, A, Barrios, C H, Holmes, F A, Mansi, J, Iwata, H, Ejlertsen, B, Moy, B, Chia, S K L, Gnant, M, Smichkoska, S, Ciceniene, A, Martinez, N, Filipović, S, Ben-Baruch, N E, Joy, A A, Langkjer, S T, Senecal, F, de Boer, R H, Moran, S, Yao, B, Bryce, R, Auerbach, A, Fallowfield, L & Martin, M 2019, ' Effects of neratinib on health-related quality of life in women with HER2-positive early-stage breast cancer : longitudinal analyses from the randomized phase III ExteNET trial ', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 30, no. 4, pp. 567-574 . https://doi.org/10.1093/annonc/mdz016Test

مصطلحات موضوعية: 0301 basic medicine, Adult, medicine.medical_specialty, early-stage breast cancer, Receptor, ErbB-2, Population, Antineoplastic Agents, Breast Neoplasms, Placebo, Disease-Free Survival, Placebos, 03 medical and health sciences, Young Adult, 0302 clinical medicine, Breast cancer, Double-Blind Method, Trastuzumab, Internal medicine, HER2, medicine, Adjuvant therapy, Humans, Imputation (statistics), Longitudinal Studies, education, Aged, Neoplasm Staging, Aged, 80 and over, education.field_of_study, business.industry, Cancer, Hematology, Middle Aged, medicine.disease, health-related quality of life, neratinib, 030104 developmental biology, Oncology, Chemotherapy, Adjuvant, patient-reported outcomes, 030220 oncology & carcinogenesis, Neratinib, Quality of Life, Quinolines, Female, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64ba1f22a813215af6018089c4ca9167Test
https://pure.au.dk/portal/da/publications/effects-of-neratinib-on-healthrelated-quality-of-life-in-women-with-her2positive-earlystage-breast-cancerTest(38fa4be9-a02a-4768-9c96-decbf86a9e95).html

المؤلفون: T. Dongsgaard, Sven Tyge Langkjer, Lars Stenbygaard, Helle Lemvig Kruse, Julia Kenholm, Anne Sofie Brems-Eskildsen, Jeanette Dupont Jensen, Hella Danø, Bjørnar Gilje, Kim Wedervang, J. Neimann, Jürgen Geisler, Erik Hugger Jacobsen, Vesna Glavicic, Mie Grunnet, Annette Torbøl Brixen

المصدر: Langkjer, S T, Kenholm, J, Jensen, J D, Wedervang, K, Brixen, A T, Grunnet, M, Stenbygaard, L, Gilje, B, Danø, H, Glavicic, V, Jacobsen, E H, Brems-Eskildsen, A S, Kruse, H L, Dongsgaard, T, Neimann, J & Geisler, J 2019, ' The NAME trial : A direct comparison of classical oral Navelbine versus Metronomic Navelbine in metastatic breast cancer ', Future Oncology, vol. 15, no. 22, pp. 2561-2569 . https://doi.org/10.2217/fon-2019-0124Test
Langkjer, S T, Kenholm, J, Jensen, J D, Wedervang, K, Brixen, A T, Grunnet, M, Stenbygaard, L, Gilje, B, Danø, H, Glavicic, V, Jacobsen, E H, Brems-Eskildsen, A S, Kruse, H L, Dongsgaard, T, Neimann, J & Geisler, J 2019, ' The NAME trial : a direct comparison of classical oral Navelbine versus metronomic Navelbine in metastatic breast cancer ', Future Oncology, vol. 15, no. 22, pp. 2561-2569 . https://doi.org/10.2217/fon-2019-0124Test

مصطلحات موضوعية: Adult, 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Maximum Tolerated Dose, medicine.medical_treatment, Navelbine, Breast Neoplasms, Vinblastine, chemotherapy, Vinorelbine, metronomic, 03 medical and health sciences, breast cancer, 0302 clinical medicine, Breast cancer, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Dosing, Neoplasm Metastasis, Lung cancer, skin and connective tissue diseases, Aged, Chemotherapy, NAME, business.industry, Drug Administration Routes, Cancer, General Medicine, Middle Aged, medicine.disease, Metastatic breast cancer, vinorelbine, Clinical trial, 030104 developmental biology, 030220 oncology & carcinogenesis, Administration, Metronomic, Quality of Life, Administration, Intravenous, Female, Phase II trial, business, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd3e68144dbea7113137cab419868c36Test
http://hdl.handle.net/10852/77735Test

المؤلفون: Sven Tyge Langkjer, Søren Linnet, Tamás Lörincz, Anne Sofie Brems-Eskildsen, Kristina B. Kristoffersen

المصدر: Brems-Eskildsen, A S, Kristoffersen, K B, Linnet, S, Lörincz, T & Langkjer, S T 2019, ' Efficacy and toxicity of eribulin treatment in metastatic breast cancer patients ', Acta Oncologica, vol. 58, no. 1, pp. 119-121 . https://doi.org/10.1080/0284186X.2018.1497301Test

مصطلحات موضوعية: Adult, Oncology, medicine.medical_specialty, PHASE-3, medicine.medical_treatment, MEDLINE, MESYLATE, Antineoplastic Agents, Breast Neoplasms, Kaplan-Meier Estimate, Disease, CAPECITABINE, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Breast cancer, Internal medicine, medicine, Carcinoma, Humans, Radiology, Nuclear Medicine and imaging, 030212 general & internal medicine, Furans, Aged, Retrospective Studies, Chemotherapy, business.industry, Carcinoma, Ductal, Breast, Retrospective cohort study, Hematology, General Medicine, Ketones, Middle Aged, medicine.disease, OPEN-LABEL, Metastatic breast cancer, PRETREATED PATIENTS, Carcinoma, Lobular, Treatment Outcome, chemistry, 030220 oncology & carcinogenesis, Female, business, Eribulin

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f87345f38f38777fd881cd2703f1be93Test
https://pure.au.dk/portal/da/publications/efficacy-and-toxicity-of-eribulin-treatment-in-metastatic-breast-cancer-patientsTest(067b9663-e667-4f9e-9e8a-37754ae48909).html

المؤلفون: Adam Luczak, Søren Linnet, J. Neimann, A. S. Brems-Eskildsen, T. Dongsgaard, H. A. Nielsen, Sven Tyge Langkjer, E. H. Jacobsen, Peter Michael Vestlev, C. B. Jensen

المصدر: European Journal of Cancer. 57:S19-S153

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Chemotherapy, business.industry, medicine.medical_treatment, HER2 negative, Vinorelbine, medicine.disease, Metronomic Chemotherapy, Capecitabine, Breast cancer, Internal medicine, Medicine, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::ea5f8ce6de41057e12e0b3d9dc540e3dTest
https://doi.org/10.1016/s0959-8049Test(16)31962-1

المؤلفون: Lena Have Rosvig, Anders Bonde Jensen, Sven Tyge Langkjer, Ann Knoop

المصدر: Rosvig, L H, Jensen, A B, Langkjer, S T & Knoop, A 2018, ' Carboplatin-regime som behandlingsmulighed til senstadie brystkræft ', Best Practice Oncology .
Aarhus University

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::89a659a584091b1cd8fe2235804e1313Test
https://pure.au.dk/portal/da/publications/carboplatinregime-som-behandlingsmulighed-til-senstadie-brystkraeftTest(9a1ca169-65a4-4ff5-a705-c1b25d42a3a0).html

المؤلفون: Troels Dreier Christensen, Anna Sofie Kappel Buhl, Jurij Bogovic, Knud Mejer Nelausen, Ib Jarle Christensen, Eva Harder Brix, Ann Knoop, Else Svensson, Steen Knudsen, Sven Tyge Langkjer, Søren Linnet, Adam Luczak, Anker Jon Hansen, Peter Buhl Jensen, Eva Balslev, Erik Jakobsen, Dorte Nielsen, Bent Ejlertsen, Annie Rasmussen, Vesna Glavicic

المصدر: Buhl, A S K, Christensen, T D, Christensen, I J, Nelausen, K M, Balslev, E, Knoop, A S, Brix, E H, Svensson, E, Glavicic, V, Luczak, A, Langkjer, S T, Linnet, S, Jakobsen, E H, Bogovic, J, Ejlertsen, B, Rasmussen, A, Hansen, A, Knudsen, S, Nielsen, D & Jensen, P B 2018, ' Predicting efficacy of epirubicin by a multigene assay in advanced breast cancer within a Danish Breast Cancer Cooperative Group (DBCG) cohort : a retrospective-prospective blinded study ', Breast Cancer Research and Treatment, vol. 172, no. 2, pp. 391-400 . https://doi.org/10.1007/s10549-018-4918-4Test
Buhl, A S K, Christensen, T D, Christensen, I J, Nelausen, K M, Balslev, E, Knoop, A S, Brix, E H, Svensson, E, Glavicic, V, Luczak, A, Langkjer, S T, Linnet, S, Jakobsen, E H, Bogovic, J, Ejlertsen, B, Rasmussen, A, Hansen, A, Knudsen, S, Nielsen, D & Jensen, P B 2018, ' Predicting efficacy of epirubicin by a multigene assay in advanced breast cancer within a Danish Breast Cancer Cooperative Group (DBCG) cohort : a retrospective-prospective blinded study ', Breast Cancer Research and Treatment, vol. 172, no. 2, pp. 391–400 . https://doi.org/10.1007/s10549-018-4918-4Test
Breast Cancer Research and Treatment

مصطلحات موضوعية: 0301 basic medicine, Oncology, RNA, Messenger/genetics, Cancer Research, Biomarkers, Pharmacological, 0302 clinical medicine, Neoplasm Proteins/genetics, Clinical endpoint, Prospective Studies, Precision Medicine, Prospective cohort study, Precision medicine, Hazard ratio, Middle Aged, Clinical Trial, Neoplasm Proteins, Gene Expression Regulation, Neoplastic, Predictive biomarker, 030220 oncology & carcinogenesis, Cohort, Disease Progression, Advanced breast cancer, Female, Epirubicin, medicine.drug, Adult, medicine.medical_specialty, Breast Neoplasms, Epirubicin/administration & dosage, Disease-Free Survival, 03 medical and health sciences, Breast cancer, Breast Neoplasms/drug therapy, Internal medicine, medicine, Humans, RNA, Messenger, Aged, Proportional Hazards Models, Retrospective Studies, Proportional hazards model, business.industry, Cancer, medicine.disease, 030104 developmental biology, Gene Expression Regulation, Neoplastic/drug effects, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f4d0f127f0dafb654c610d7a725c80aTest
https://curis.ku.dk/portal/da/publications/predicting-efficacy-of-epirubicin-by-a-multigene-assay-in-advanced-breast-cancer-within-a-danish-breast-cancer-cooperative-group-dbcg-cohortTest(d94324d4-b6ee-484b-9f67-4ebcfeaf6560).html